Skip to content
lifestyle.entreprenerd.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
RIGEL PHARMACEUTICALS, INC.
Rigel Announces Conference Call and Webcast to Report First Quarter 2026 Financial Results
April 28, 2026
Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology
March 31, 2026
←
Previous Page
1
2